I cannot comment on POTS in general and I find it possible that there may be instances where it has its use (for example there might be a different "group" of doctors outside of the Lyme/ME/CFS/Long-Covid "communities" where POTS is used in a different context even though the article at the bottom of the page suggests this needn't be the case).*
However, I do think that there is a problem more specifically within the ME/CFS sphere (including Long-Covid, Lyme ect doctors and organisations in this field) for POTS. In this sphere POTS is often used to synonymously to describe the orthostatic problems that people with ME/CFS describe. However, there is some strong evidence (that has been discussed on this forum at length) that suggests that the orthostatic problems in ME/CFS are in no way described by POT. In short: Take a person with ME/CFS that describes having significant OI and take a matched healthy control. If you run a tilt table test on them, there is strong evidence that suggests that the results will be exactly the same or more specifically that you cannot tell them apart on the basis of the results, i.e. POT doesn't characterise ME/CFS status nor the OI experienced. This doesn't just apply to the individual but as far as I can see there isn't evidence to suggest that there would be significant group differences in a well controlled study. That is compounded with the very significant problem of very low rates of reproducibility in this field, in part because POT can be affected by many things.
On the other side there have been some studies in the ME/CFS field which suggest POT does carry significance, but I think those studies have almost all been of a very poor standard and with the above strong evidence probably don't count for anything. There is a part of the POTS field that is very much just the same low quality memes we see in ME/CFS: One year POTS is caused by GPCR-aab, the next by microclots...
*There is quite a bit of general POTS research that suggests that picking out POT specifically is rather arbitrary, this is well known and documented in the field and people have tried establishing other things such as the MALMÖ symptom burden score. Why they have specifically hung onto POT isn't quite clear to me, maybe there has also been some high quality POTS research somewhere along the line and maybe it is justified outside of the "ME/CFS field", but it doesn't seem to help in the context of ME/CFS as far as I can see.
As always I find the following piece a great reference:
https://mecfsscience.org/the-problems-with-pots/. The other side of the medallion is that a POTS researcher will say: There is no evidence to suggest that PEM characterises the symptoms experienced by people with ME/CFS.